Investigators explored the association between income and patient- and treatment characteristics, diagnosis through screening, and survival of patients with synchronous metastasized CRC.

To conclude his conversation with AJMC, Jordan Karlitz, MD, outlines clinical, behavioral, and policy strategies to reverse rising CRC deaths in adults aged under 50. Regarding clinical interventions, ...

A Supreme Court case may jeopardize free CRC screenings, risking increased out-of-pocket costs and reversing public health progress. Biological age, rather than chronological age, may better predict ...

A prospective cohort study explored the effect of adherence to follow-up colonoscopy after positive FOBT on risk of developing colon cancer ...

A retrospective study of data from patients aged 50 to 75 years in the Kaiser Permanente Northern California health system showed detection of colorectal cancer by colonoscopy fell by 4% in 2020 vs ...

Colorectal cancer (CRC) is the second most commonly diagnosed cancer in China and a leading cause of cancer-related mortality. Despite improvements in treatment, the survival rate remains lower than ...

Guardant Health has reported an encouraging clinical readout update on the performance of its latest algorithm for the Shield blood test for colorectal cancer (CRC) screening. The latest screening ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “More than three out of four Americans who die from ...

– Study met all primary endpoints, including 79.2% sensitivity for colorectal cancer (CRC) and 91.5% specificity for non-advanced colorectal neoplasia – – PREEMPT CRC, the largest study of a ...

Colorectal cancer diagnoses in Puerto Rico dropped significantly during and after Hurricanes Irma and Maria, and the COVID-19 pandemic, but later rebounded, revealing troubling concerns about the ...

Mark Stenhouse left his executive role at AbbVie to join Exact Sciences because he felt the company was fighting a worthy battle: preventing colorectal cancer. Mr. Stenhouse, now Exact Science’s ...